ClearPoint Neuro CLPT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29.07M-13.8% | -$25.54M-10.4% | -$23.14M-4.1% | -$22.22M-6.9% | -$20.79M-9.9% | ||
| $797K-2.1% | $814K+1.1% | $805K-19.7% | $1M+19.4% | $840K-14.3% | ||
| $8.49M+3.8% | $8.18M+3.5% | $7.9M+1.5% | $7.78M+6.5% | $7.31M+5.8% | ||
| $125K+50.6% | $83K+38.3% | $60K+39.5% | $43K+19.4% | $36K-29.4% | ||
| —— | —— | —— | —— | —— | ||
| $3.13M+1,069% | $268K-51.4% | $552K-54.5% | $1.21M+0.6% | $1.21M0.0% | ||
| $306K+197% | $103K+135% | -$293K+81.0% | -$1.55M-101% | -$768K-3.4% | ||
| —— | —— | —— | —— | $1.15M-62.8% | ||
| —— | —— | $522K+224% | -$420K-58.5% | -$265K-1.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| -$1.17M-15.5% | -$1.01M-6.5% | -$950K-1.2% | -$939K-0.8% | -$932K-7.2% | ||
| -$25.7M-7.5% | -$23.9M-82.6% | -$13.09M-17.2% | -$11.17M+1.0% | -$11.28M-26.1% | ||
| $984K+88.5% | $522K-29.1% | $736K+34.1% | $549K+19.9% | $458K+66.5% | ||
| —— | $1.14M+33.3% | $852.75K+50.0% | $568.5K+100% | $284.25K— | ||
| $153K-75.1% | $615K+184% | -$736K-34.1% | -$549K-19.9% | -$458K-66.5% | ||
| —— | —— | —— | —— | —— | ||
| $2.54M+37.1% | $1.86M+6.4% | $1.75M-3.4% | $1.81M+14.4% | $1.58M+272% | ||
| $49.7M-1.0% | $50.18M+63.7% | $30.65M— | —— | —— | ||
| —— | —— | —— | $8.88M+139% | -$22.97M-656% | ||
| $1.43M+57.8% | $908K+85.3% | $490K+73.8% | $282K-4.4% | $295K-38.5% | ||
| $69K0.0% | $69K-23.3% | $90K+173% | $33K-46.8% | $62K0.0% | ||
| $125K+50.6% | $83K+38.3% | $60K+39.5% | $43K+19.4% | $36K-29.4% | ||
| —— | —— | —— | —— | $0— | ||
| -$1.17M-15.5% | -$1.01M-6.5% | -$950K-1.2% | -$939K-0.8% | -$932K-7.2% | ||
| $266K+36.4% | $195K— | —— | —— | —— | ||
| —— | —— | $522K+224% | -$420K-58.5% | -$265K-1.1% | ||
| $1.43M+57.8% | $908K+85.3% | $490K+185% | $172K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1.17M-15.5% | -$1.01M-6.5% | -$950K-1.2% | -$939K-0.8% | -$932K-7.2% | ||
| -$26.68M-9.2% | -$24.42M-76.7% | -$13.82M-18.0% | -$11.72M+0.2% | -$11.74M-27.3% | ||
| -$26.68M-9.2% | -$24.42M-76.7% | -$13.82M-18.0% | -$11.72M+0.2% | -$11.74M-27.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ClearPoint Neuro generate?
- ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
- What is ClearPoint Neuro's free cash flow?
- After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
- Where does ClearPoint Neuro's cash flow data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
